Catalyst Pharmaceuticals

+$0.39 (+7.83%) As of 5:17 PM UTC today

Why Robinhood?

You can buy or sell CPRX and other stocks, options, and ETFs commission-free!

About CPRX

Catalyst Pharmaceuticals, Inc. Common Stock, also called Catalyst Pharmaceuticals, is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms.

CEO
Patrick J. McEnany
Employees
74
Headquarters
Coral Gables, Florida
Founded
2002

CPRX Key Statistics

Market Cap
557.43M
Price-Earnings Ratio
7.16
Dividend Yield
—
Average Volume
1.65M
High Today
$5.40
Low Today
$4.99
Open Price
$5.00
Volume
1.18M
52 Week High
$5.40
52 Week Low
$2.88

CPRX Earnings

$0.07
$0.09
$0.11
$0.13
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$0.09 per share
Actual
$0.07 per share
Replay Earnings Call

You May Also Like

HBCP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure